Newsletter | July 31, 2024

07.31.24 -- Uncovering Cell Culture Media's Part In Latest Biopharma Trends

SPONSOR

Introducing the 3rd Cell Therapy Analytical Development Europe, your unmissable opportunity to connect with peers, share pain points and establish analytical standards for smoother interactions with regulatory bodies including the FDA, EMA and MHRA. Seize the chance this September to collaborate, connect and share insights to drive the future development of potent, safe and effective autologous and allogeneic cell therapies forward!

FEATURED EDITORIAL

Uncovering Cell Culture Media's Part In Latest Biopharma Trends

Cell culture media are ubiquitous in just about every bioprocess system, and advanced modalities are putting specialty media in the spotlight.

INDUSTRY INSIGHTS

Bridging The Gap Between Cell And Gene Therapy Promise And Practicality

Delve into the current challenges and opportunities of therapeutic targets, manufacturing processes, and regulatory frameworks for CGTs and realize the full potential of these revolutionary therapies.

Advance Biomanufacturing Processes And Drug Product Stability

Improve upstream media for bioavailability and foam stability, downstream buffers for purification, and the formulation and final fill drug product stability with this highly interdisciplinary process.

The Difficulties Of Working With Multiple Siloed Partners

By working with a single supplier that can handle the entire manufacturing value chain, companies can reduce risk, improve flexibility, and accelerate their time to market.

A Focused Approach: Aiming To Simplify Biological Drug Production

Learn how using advanced technologies in an end-to-end process can help companies optimize the production process and reduce potential risks in biological drug production.

SOLUTIONS

The Comprehensive Cell Therapy CDMO, From R&D To cGMP Manufacturing

Small Scale Feasibility

Connect With Cell & Gene: